Rifampicin exposure reveals within-host Mycobacterium tuberculosis diversity in patients with delayed culture conversion
Authors:
- Charlotte GenestetCGCharlotte Genestet
- Elisabeth HodilleEHElisabeth Hodille
- Alexia BarbryABAlexia Barbry
- Jean-Luc BerlandJBJean-Luc Berland
- Jonathan HoffmannJHJonathan Hoffmann
- Emilie WesteelEWEmilie Westeel
- Fabiola BastianFBFabiola Bastian
- Michel GuichardantMGMichel Guichardant
- Samuel VennerSVSamuel Venner
- Gérard LinaGLGérard Lina
- Christophe GinevraCGChristophe Ginevra
- Florence AderFAFlorence Ader
Preprint
Abstract
Mycobacterium tuberculosis (Mtb) genetic micro-diversity in clinical isolates may underline mycobacterial adaptive response during the course of tuberculosis (TB) and provide insights to anti-TB treatment response and emergence of resistance. Herein we followed within-host evolution of Mtb clinical isolates in a cohort of patients with delayed Mtb culture conversion. We captured the genetic diversity of both the initial and the last Mtb isolate obtained in each patient, by focusing on minor variants detected as unfixed single nucleotide polymorphisms (SNPs). To unmask antibiotic tolerant sub-populations, we exposed the last Mtb isolate to rifampicin (RIF) prior to whole genome sequencing analysis. We were able to detect unfixed SNPs within the Mtb isolates for 9/12 patients, and non-synonymous (ns) SNPs in 6/12 patients. Furthermore, RIF exposure revealed 8 additional unfixed nsSNP unlinked to drug resistance. To better understand the dynamics of Mtb micro-diversity during the course of TB, we investigated the variant composition of a persistent Mtb clinical isolate before and after controlled stress experiments chosen to mimic the course of TB disease. A minor variant, featuring a particular mycocerosates profile, became enriched during both RIF exposure and macrophage infection. The variant was associated with drug tolerance and intracellular persistence, consistent with the pharmacological modeling predicting increased risk of treatment failure. A thorough study of such variants, not necessarily linked to canonical drug-resistance and which may be able to promote anti-TB drug tolerance, may be crucial to prevent the subsequent emergence of resistance. Taken together, the present findings support the further exploration of Mtb micro-diversity as a promising tool to detect patients at risk of poorly responding to anti-TB treatment, ultimately allowing improved and personalized TB management. Author summary: Tuberculosis (TB) is caused by Mycobacterium tuberculosis (Mtb), bacteria that are able to persist inside the patient for many months or years, thus requiring long antibiotic treatments. Here we focused on TB patients with delayed response to treatment and we performed genetic characterization of Mtb isolates to search for sub-populations that may tolerate anti-TB drugs. We found that Mtb cultured from 9/12 patients contained different sub-populations, and in vitro drug exposure revealed 8 other sub-populations, none related to known drug-resistance mechanisms. Furthermore, we characterized a Mtb variant isolated from a sub-population growing in the presence of rifampicin (RIF), a major anti-TB drug. We found that this variant featured a modified lipidic envelope, and that it was able to develop in the presence of RIF and inside human macrophage cells. We performed pharmacological modelling and found that this kind of variant may be related to a poor response to treatment. In conclusion, searching for particular Mtb sub-populations may help to detect patients at risk of treatment failure and provide additional guidance for TB management.Keywords
This publication has 67 references indexed in Scilit:
- Effects of Host, Sample, and in vitro Culture on Genomic Diversity of Pathogenic MycobacteriaFrontiers in Genetics, 2019
- Subcultured Mycobacterium tuberculosis isolates on different growth media are fully representative of bacteria within clinical samplesTuberculosis, 2019
- Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture SequencingJournal of Clinical Microbiology, 2018
- Same-Day Diagnostic and Surveillance Data for Tuberculosis via Whole-Genome Sequencing of Direct Respiratory SamplesJournal of Clinical Microbiology, 2017
- Antibiotic tolerance facilitates the evolution of resistanceScience, 2017
- Genomic diversity in autopsy samples reveals within-host dissemination of HIV-associated Mycobacterium tuberculosisNature Medicine, 2016
- Whole Genome Sequence Analysis of a Large Isoniazid-Resistant Tuberculosis Outbreak in London: A Retrospective Observational StudyPLOS Medicine, 2016
- Diversity of Mycobacterium tuberculosis across Evolutionary ScalesPLOS Pathogens, 2015
- Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical SamplesJournal of Clinical Microbiology, 2015
- Drug Tolerance in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1999